{"id":8511,"date":"2025-07-23T01:19:58","date_gmt":"2025-07-23T06:19:58","guid":{"rendered":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/"},"modified":"2025-07-30T11:12:55","modified_gmt":"2025-07-30T16:12:55","slug":"chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf","status":"publish","type":"article","link":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/","title":{"rendered":"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF"},"content":{"rendered":"<p>To date, there are no known or documented contraindications for HDF. Therefore, in principle, all dialysis patients could benefit from the advantages of HVHDF. To implement HVHDF effectively in a clinic where all patients are currently receiving high-flux HD, the following prioritization rules are recommended:<\/p>\n<h2>9.1\u00a0 | Eligibility Criteria<\/h2>\n<p>Before considering the switch from high-flux dialysis to post-dilution HVHDF, it is suggested to evaluate if patients meet the following baseline requirements:<\/p>\n<ul>\n<li>Blood flow rate \u2265 330 ml\/min. A well-functioning AVF is preferred. Patients with CVCs or AVGs may be considered if they can achieve Qb &gt; 330 ml\/min.<\/li>\n<li>Treatment time \u2265 210 minutes\/session.<\/li>\n<li>Anticoagulants: Preventing clotting within the extracorporeal circuit is mandatory to optimize HDF efficacy and ensure patient safety.<\/li>\n<li>Normal blood viscosity: Patients with high blood viscosity (e.g., polycythemia, high blood concentration of fibrinogen and lipids) are at higher risk of fiber clogging.<\/li>\n<\/ul>\n<h2>9.2\u00a0 | Prioritization Based on Clinical Benefit<\/h2>\n<p>Once eligibility is confirmed, prioritize patients based on the potential benefits of HVHDF:<\/p>\n<ol style=\"list-style-type: upper-alpha;\">\n<li><strong>High Priority<\/strong>\n<ol>\n<li>Patients capable of achieving high convection volumes \u2265 23 L\/session.<\/li>\n<li>Patients on active kidney transplantation list.<\/li>\n<li>Patients with hemodynamic instability.<\/li>\n<li>Patients with heart failure, coronary artery disease.<\/li>\n<li>Patients with high ultrafiltration needs requiring substantial fluid removal.<\/li>\n<li>Patients with large body size.<\/li>\n<\/ol>\n<\/li>\n<li><strong>Moderate Priority<\/strong>\n<ol>\n<li>Patients with residual kidney function. Those maintaining urine output &gt;1000 mL\/24 hours may experience improved toxin clearance with HVHDF.<\/li>\n<li>Patients with elevated serum phosphorus levels.<\/li>\n<li>Patients with dialysis-related amyloidosis.<\/li>\n<li>Patients with worsening nutritional status.<\/li>\n<li>Patients with polyneuropathy.<\/li>\n<li>Patients with itching.<\/li>\n<\/ol>\n<\/li>\n<li><strong>Lower Priority<\/strong>\n<ol>\n<li>Patients with limited vascular access. Individuals with CVCs or AVGs that cannot achieve high Qbs may not realize the full benefits of HVHDF.<\/li>\n<li>Patients with shorter session durations. Those unable to undergo 4-hour sessions may not achieve the necessary convection volumes for optimal HVHDF efficacy.<\/li>\n<li>Patients who are not compliant with the dialysis procedure and accompanying prescriptions, mainly the frequency and duration of dialysis treatment, should have lower priority.<\/li>\n<li>Patients with life expectancy of less than 3 months.<\/li>\n<li>Patients intolerant of heparin or anticoagulants.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<h2>9.3\u00a0 | Implementation Considerations<\/h2>\n<ul>\n<li>Gradual transition: Begin with high-priority patients, monitoring their response closely before expanding to other groups.<\/li>\n<li>Monitor convection volumes: To maximize HVHDF benefits, aim for a target convection volume of &gt; 23 liters per session.<\/li>\n<li>Patient education: Inform patients about the potential advantages and any risks associated with HVHDF to ensure informed decision-making.<\/li>\n<li>Resource assessment: Ensure the availability of necessary equipment and trained staff to support HVHDF therapy.<\/li>\n<li>By adhering to these criteria, clinics can effectively identify and prioritize patients who are most likely to benefit from transitioning to HVHDF, thereby optimizing clinical outcomes and resource utilization.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"featured_media":0,"template":"","format":"standard","meta":{"_acf_changed":false},"categories":[128],"tags":[250],"language":[41],"articles":[215],"class_list":["post-8511","article","type-article","status-publish","format-standard","hentry","category-articles","tag-handbook-hdf","language-english","articles-hemodiafiltration","entry","no-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.advancedrenaleducation.com\/wparep\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific\" \/>\n<meta property=\"og:description\" content=\"To date, there are no known or documented contraindications for HDF. Therefore, in principle, all dialysis patients could benefit from the advantages of HVHDF. To implement HVHDF effectively in a clinic where all patients are currently receiving high-flux HD, the&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/\" \/>\n<meta property=\"og:site_name\" content=\"AREP Asia Pacific\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-30T16:12:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/\",\"url\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/\",\"name\":\"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific\",\"isPartOf\":{\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#website\"},\"datePublished\":\"2025-07-23T06:19:58+00:00\",\"dateModified\":\"2025-07-30T16:12:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#website\",\"url\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/\",\"name\":\"AREP Asia Pacific\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#organization\",\"name\":\"AREP Asia Pacific\",\"url\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-content\/uploads\/sites\/11\/2023\/03\/1Asset-1.jpg\",\"contentUrl\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-content\/uploads\/sites\/11\/2023\/03\/1Asset-1.jpg\",\"width\":1965,\"height\":381,\"caption\":\"AREP Asia Pacific\"},\"image\":{\"@id\":\"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.advancedrenaleducation.com\/wparep\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/","og_locale":"en_US","og_type":"article","og_title":"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific","og_description":"To date, there are no known or documented contraindications for HDF. Therefore, in principle, all dialysis patients could benefit from the advantages of HVHDF. To implement HVHDF effectively in a clinic where all patients are currently receiving high-flux HD, the&hellip;","og_url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/","og_site_name":"AREP Asia Pacific","article_modified_time":"2025-07-30T16:12:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/","url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/","name":"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF - AREP Asia Pacific","isPartOf":{"@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#website"},"datePublished":"2025-07-23T06:19:58+00:00","dateModified":"2025-07-30T16:12:55+00:00","breadcrumb":{"@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/article\/chapter-9-strategy-to-prioritize-patient-selection-for-the-implementation-of-hvhdf\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/"},{"@type":"ListItem","position":2,"name":"Chapter 9 | Strategy to prioritize patient selection for the implementation of HVHDF"}]},{"@type":"WebSite","@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#website","url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/","name":"AREP Asia Pacific","description":"","publisher":{"@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#organization","name":"AREP Asia Pacific","url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#\/schema\/logo\/image\/","url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-content\/uploads\/sites\/11\/2023\/03\/1Asset-1.jpg","contentUrl":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-content\/uploads\/sites\/11\/2023\/03\/1Asset-1.jpg","width":1965,"height":381,"caption":"AREP Asia Pacific"},"image":{"@id":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/#\/schema\/logo\/image\/"}}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"AREP Asia Pacific","distributor_original_site_url":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific","push-errors":false,"_links":{"self":[{"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/article\/8511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/media?parent=8511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/categories?post=8511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/tags?post=8511"},{"taxonomy":"language","embeddable":true,"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/language?post=8511"},{"taxonomy":"articles","embeddable":true,"href":"https:\/\/staging.advancedrenaleducation.com\/wparep\/asiapacific\/wp-json\/wp\/v2\/articles?post=8511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}